APOE and Alzheimer disease: From animal models to human postmortem autopsy and Aβ PET studies, it has been shown that Apo-E4 promotes the deposition of Aβ and inhibits degradation of it in AD resulting in symptom development, while no direct interaction between Apo-E and TAU proteins has been introduced.